Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1985 Jul;20(1):89–90. doi: 10.1111/j.1365-2125.1985.tb02804.x

Slow release choline theophyllinate (Sabidal SR 270) in chronic asthma.

S J Berg, L P Balant, I Clarke, A J Fairfax
PMCID: PMC1400634  PMID: 4027142

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dahlqvist R., Billing B. Pharmacokinetic properties of a new sustained-release theophylline preparation. Int J Clin Pharmacol Ther Toxicol. 1983 Feb;21(2):69–72. [PubMed] [Google Scholar]
  2. Jones R. W. Comparative pharmacokinetics of two theophylline derivatives in asthmatic patients. J Int Med Res. 1979;7 (Suppl 1):16–21. [PubMed] [Google Scholar]
  3. Leung P., Katsampes C., Bell T. Pharmacokinetics of delayed (DR) versus sustained release (SR) theophylline formulations following single (SD) and repetitive dosing (RD). Ann Allergy. 1978 Nov;41(5):285–287. [PubMed] [Google Scholar]
  4. Trembath P. W., Boobis S. W., Richens A. Theophylline: biochemical pharmacology and pharmacokinetics. J Int Med Res. 1979;7 (Suppl 1):4–15. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES